Are Foot Orthoses Effective at Reducing Pain in Adults with Foot Osteoarthritis? by Kemmerer, Jacob T
Philadelphia College of Osteopathic Medicine 
DigitalCommons@PCOM 
PCOM Physician Assistant Studies Student 
Scholarship Student Dissertations, Theses and Papers 
2020 
Are Foot Orthoses Effective at Reducing Pain in Adults with Foot 
Osteoarthritis? 
Jacob T. Kemmerer 
Philadelphia College of Osteopathic Medicine 
Follow this and additional works at: https://digitalcommons.pcom.edu/pa_systematic_reviews 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Kemmerer, Jacob T., "Are Foot Orthoses Effective at Reducing Pain in Adults with Foot Osteoarthritis?" 
(2020). PCOM Physician Assistant Studies Student Scholarship. 513. 
https://digitalcommons.pcom.edu/pa_systematic_reviews/513 
This Selective Evidence-Based Medicine Review is brought to you for free and open access by the Student 
Dissertations, Theses and Papers at DigitalCommons@PCOM. It has been accepted for inclusion in PCOM 
Physician Assistant Studies Student Scholarship by an authorized administrator of DigitalCommons@PCOM. For 
more information, please contact library@pcom.edu. 
 









Jacob T. Kemmerer, PA-S  
A SELECTIVE EVIDENCE BASED MEDICINE REVIEW 
In Partial Fulfillment of the Requirements For  
The Degree of Master of Science 
In 
Health Sciences – Physician Assistant 
 
 
Department of Physician Assistant Studies 









OBJECTIVE: The objective of this selective EBM review is to determine whether or not “Are 
foot orthoses effective at reducing pain in adults with foot osteoarthritis?” 
 
STUDY DESIGN: A review of two randomized controlled trials and one case series from peer-
reviewed journals published between 2010 and 2016.  
 
DATA SOURCES: Two randomized controlled trials and one case series were found using 
PubMed. 
 
OUTCOME MEASURED: Reduction of the subject’s foot pain was the patient-oriented 
outcome measured in each of these three articles. The subject’s pain was scored on a Likert scale 
and evaluated at baseline and at 12 weeks to assess their response to foot orthoses. 
 
RESULTS: The first randomized controlled trial analyzed determined that prefabricated foot 
orthoses improved subject Foot Health Status Questionnaire (FHSQ) pain domain scores similar 
to rocker-sole footwear in patients with 1st metatarsophalangeal joint osteoarthritis (Menz HB, 
Auhl M, Tan JM, Levinger P, Roddy E, Munteanu SE. Arthritis Care Res. 2016;68(5):581-589. doi: 
10.1002/acr.22750 [doi]). A case series determined that custom-made semi-rigid foot orthoses 
with or without carbon fiber foot plates reduced average pain scores in patients with midfoot 
osteoarthritis (Ibuki A, Cornoiu A, Clarke A, et al. Prosthet Orthot Int. 2010;34(4):461-471. doi: 
10.3109/03093646.2010.503672.). The final randomized controlled trial examined found that 
functional foot orthoses (FFO) did reduce subject “average pain in the month” questionnaire 
scores similar to sham orthoses in adults with midfoot osteoarthritis. However, the study had a 
wide estimate of treatment effect making it difficult to determine if there was a difference 
between interventions (Chapman GJ, Halstead J, Redmond AC. Gait Posture. 2016;49:235-240. 
doi: 10.1016/j.gaitpost.2016.07.012.).  
CONCLUSIONS: The two randomized controlled trials and one case series in this review 
showed some data to suggest foot orthoses are effective at reducing pain in adults with foot 
osteoarthritis. However, future randomized controlled trials are needed to determine if foot 
orthoses are superior to other treatment options for foot osteoarthritis. 
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INTRODUCTION 
Osteoarthritis (OA) is the most common type of arthritis, where all structures of the joint 
have undergone pathologic change leading to joint failure. OA commonly affects the cervical 
and lumbosacral spine, proximal and distal interphalangeal joints of the hands, carpometacarpal 
joint of the thumb, as well as joints of the hip, knee, and feet.1 Within the foot, the first 
metatarsophalangeal (MTP) joint is most commonly affected, followed by the second 
cuneometatarsal and talonavicular joints.2  
It is estimated 22.7% (54.4 million) of adults in the United States have doctor diagnosed 
arthritis, with significantly higher age-adjusted prevalence in women (23.5%) than in men 
(18.1%).3 About 43.5% (23.7 million) of 54.4 million adults with doctor-diagnosed arthritis have 
limitations in their usual activities due to their arthritis.3 As the US population continues to age, 
the prevalence of doctor-diagnosed arthritis is expected to increase. By the year 2040, an 
estimated 78.4 million adults aged 18 years and older will have doctor-diagnosed arthritis.3 Foot 
pain affects one in four people aged over 75 years, two-thirds of whom have related locomotor 
disability.2 Symptomatic foot OA affects 17% of adults aged 50 years and over.2 
In 2013, total medical care expenditures attributed to arthritis and earning losses were 
303.5 billion, or 1% of the 2013 US gross domestic product.4 In that year, OA accounted for 
$16.5 billion (4.3%) of the combined costs for all hospitalizations, second to septicemia.5 OA 
was the leading cause (46%) of hospitalizations among all arthritis diagnoses and was diagnosed 
in 23.7 million healthcare visits in 2013.6 Nearly 3 million hospital stays in 2013 had an OA 
diagnosis.6  
OA is a disease caused by hyaline articular cartilage loss, which is accompanied by 
increasing thickness and sclerosis of the subchondral bony plate, outgrowth of osteophytes at the 
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joint margin, stretching of the articular capsule, variable degrees of synovitis, and weakness of 
muscles bridging the joint.1 Joint vulnerability and joint loading are the two major factors 
contributing to the development of OA, with the cartilage being the primary target tissue for 
disease.1 
Patients with OA experience a slow onset of pain affecting one or a few joints at a time that 
is increased with joint use and relieved with rest.7 Joint stiffness is short lived (<30 minutes) and 
is early morning or inactivity related.7  Other features include mild swelling and absence of 
constitutional symptoms.7  Signs of OA include: swelling, deformity, muscle wasting, joint line 
tenderness, crepitus, and reduced range of motion.7 First MTP joint OA is usually bilateral, and 
when symptomatic leads to localized big toe pain on standing and during ambulation.7 Bony 
enlargement of the first MTP joint, hallux valgus, hallux rigidus, and cross-over toes are 
common deformities, frequently leading to the development of a complicating bursa with 
additional fibrous tissue reactions on the medial aspect of the first MTP joint.7 
Management of foot OA generally begins with conservative interventions, including 
analgesic or anti-inflammatory medications, intra-articular injections, physical therapy, footwear 
modifications, foot orthoses, and surgery.2,8 
There is currently no cure for foot OA and there are few randomized controlled trials 
demonstrating efficacy of one treatment vs. another. Foot orthoses may show to be an effective 
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OBJECTIVE 
The objective of this selective EBM review is to determine whether or not “Are foot 
orthoses effective at reducing pain in adults with foot osteoarthritis?” 
METHODS 
 Three studies on the use of foot orthoses as treatment for foot osteoarthritis in adults were 
selected for analysis. Menz et al. compared prefabricated foot orthoses vs. rocker-sole footwear 
in adults with 1st MTP OA, Ibuki et al. compared custom-made semi-rigid foot orthoses with or 
without carbon fiber foot plates in patients with midfoot OA, and Chapman et al. compared 
functional foot orthoses (FFO) vs. sham foot orthoses in adults with midfoot OA. Each study 
looked at the outcome of subject pain reduction.  
Data sources were searched using key words “foot orthoses” and “osteoarthritis”. All 
articles were published in English and in peer-reviewed journals. Articles were searched via 
PubMed and selected based on their relevance to the clinical question and that the outcome of the 
study mattered to the patient (POEM). Articles were included if they were clinical studies and 
randomized controlled trials published after 2008 on human subjects, in English language. 
Clinical studies and randomized controlled trials published in 2008 or earlier on non-human 
subjects, in non-English language were excluded. Statistics used and reported include: mean 
change from baseline, p-value, confidence interval (CI), relative risk (RR), and number needed 
to harm (NNH). Menz et al. and Chapman et al. are both randomized controlled trials, while 
Ibuki et al. is a case series. Table 1 illustrates the various characteristics of the studies analyzed 
during this selective EBM review.  
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Table 1. Demographics and characteristics of included studies.8-10 
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OUTCOME MEASURED 
 Reduction of the subject’s foot pain was the patient-oriented outcome measured in each 
of these three articles. The subject’s pain was scored on a Likert scale and evaluated at baseline 
and at 12 weeks to assess their response to foot orthoses. 
 In the study conducted by Menz et al., the outcome measured was the subject’s foot pain 
domain of the Foot Health Status Questionnaire (FHSQ), which is a foot specific, health related 
quality of life outcome measure.8 Questions within each domain are scored ranging from 0 
indicating very poor foot health to 100 indicating optimum foot health.8 Ibuki et al. developed 
patient evaluation questionnaires where patients rated their average level of pain, from 0 
indicating ‘no pain’ to 10 indicating ‘worst pain’.9 Chapman et al. assessed subject’s average 
pain in the last month using an 11-point numeric rating scale scored from ‘no pain’ to ‘pain as 
bad as you can imagine’.10 
RESULTS 
 This selective EBM review utilized two randomized controlled trials and one case series 
to determine the efficacy of foot orthoses at reducing pain in adults with foot osteoarthritis. All 
three studies took place in outpatient settings.8-10 
The first study conducted by Menz et al. was a parallel-group randomized controlled trial 
comparing prefabricated foot orthoses vs. commercially available rocker-sole footwear for the 
treatment of 1st MTP OA.8 Participants were recruited via radio, newspaper, and social media 
advertisements.8 To be included in the study, participants must be: ≥ 18 years of age, report 1st 
MTP joint pain for at least 12 weeks, have <64°of dorsiflexion ROM of the 1st MTP joint, have 
pain with palpation to the dorsal aspect of the 1st MTP joint, be able to walk >50 meters without 
assistance, abstain from additional interventions (PT, other orthoses, shoe modification, 
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injections, or surgery) during the study and willingly discontinue pain medication 14 days prior 
to and for the duration of the study.8 Participants were excluded if they were pregnant, had 
previous 1st MTP joint surgery, significant 1st MTP deformity, or had intraarticular injection (in 
the past 6 mo) of the 1st MTP joint.8 Researchers also excluded participants if they were 
diagnosed with another foot or ankle condition, a systemic inflammatory conditions, a 
connective tissue disease, cognitive impairment, had history of recurrent falls (≥ 2 in the last 
year), currently wearing contoured foot orthoses, specialized footwear or footwear that would not 
accommodate foot orthoses.8 Of the 326 assessed for eligibility, 102 participants were 
randomized using permuted block randomization to either the prefabricated foot orthoses group 
(n = 52) or the rocker-sole footwear group (n = 50).8 In the foot orthoses group, one participant 
withdrew as they could not tolerate the orthoses and four were lost to follow-up giving a 
completion rate of 90%.8 In the rocker-sole footwear group, four withdrew consent after 
randomization leaving forty-six participants who received the allocated intervention.8 Of these 
subjects, three were lost to follow up and two could not tolerate the footwear giving a completion 
rate of 89%.8 The primary outcome measure was the foot pain domain of FHSQ measured at 
baseline, 4, 8, and 12 weeks.8 In order to compare this RCT to other studies, this review focuses 
on subject FHSQ pain domain score at baseline and 12 weeks. Table 2 illustrates improvement in 
subject baseline mean score to 12-week follow up in both the functional foot orthoses group and 
rocker-sole footwear group. A p-value of 0.477 indicates there is no significant difference 
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Table 2. Subject FHSQ pain domain (0-100) score in Menz et al.8 
 Orthoses Group 
(n = 52) 
Rocker-Sole Footwear Group 
(n = 46) 
Baseline Mean ± (SD) 56.7 ± (19.2) 51.5 ± (20.3) 
12 weeks Mean ± (SD) 73.6 ± (16.8) 73.7 ± (14.8) 
Mean change from baseline (Calculated) 16.9 22.2 
P-value 0.477 
Table 3 demonstrates the most commonly reported adverse events during the Menz et al. 
study. Participants in the rocker-sole footwear group were more likely to report new onset low 
back pain during the study than the functional foot orthoses group.8 A p-value of 0.048 indicates 
statistically significant difference between the two interventions. Researchers calculated NNH is 
8 (3.9, 71.0) with 95% CI meaning that for every eight patients treated with rocker-sole 
footwear, one more patient would experience low back pain than if they were treated with 
functional foot orthoses.8 Adherence varied markedly between the two groups. Researchers 
found that the footwear group wore their shoes for an average of 287 hours in total throughout 
the 12-week study period compared to the 448 hours for the orthoses group.8  




(n = 52) 
Rocker-Sole 
Footwear Group 
(n = 46) 
Relative Risk (95% CI) P Value 
NNH 
(95% CI) 
New Low Back Pain 2 (3.8) 8 (17.4) 4.52 (1.01, 20.22) 0.048 8 (3.9, 71.0) 
Experienced Fall 5 (11.1) 4 (10.3) 0.92 (0.27, 3.20) 0.900  
Blisters 2 (3.8) 3 (6.5) 1.34 (0.45, 4.00) 0.442  
Discomfort  2 (3.8) 3 (6.5) 1.34 (0.45, 4.00) 0.442  
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Ibuki et al. conducted a case series to determine the effects of custom-made semi-rigid 
foot orthoses alone and with rigid carbon fiber footplates on adults with midfoot OA.9 Subjects 
were recruited through a private orthopedic foot and ankle clinic and were assessed by an 
orthopedic surgeon.9 Subjects met inclusion criteria if they had a diagnosis of unilateral or 
bilateral midfoot OA with radiographic evidence or had the presence of pain in the midfoot 
region.9 Subjects were excluded if they had any other symptomatic conditions of their feet or 
ankles unrelated to midfoot OA or if they previously received the same orthopedic treatment as 
prescribed in this study, i.e. semi-rigid foot orthoses or carbon fiber footplates.9 A total of 57 
subjects were included for analysis.9 All were fitted with custom-made semi-rigid foot orthoses 
and 36 (63%) also had carbon fiber footplates modified into their footwear.9 Subjects were given 
pre-treatment, 6-week, 12-week, and 24-week patient evaluation questionnaires.9 In order to 
compare to other studies, this review focuses on the ‘average level of pain’ component of the 
questionnaire pre-treatment and at 12 weeks. Table 4 shows a 1.61 mean reduction of the 
patient’s baseline average pain. Researchers calculated a p-value of <0.01, which indicates a 
statistically significant change from baseline.9 Researchers did not separate the data into foot 
orthoses alone vs. foot orthoses and carbon fiber foot plates and stated a RCT would be 
necessary to determine if the use of carbon fiber foot palates has any additional benefit to foot 
orthoses alone.9 Ibuki et al. also did not mention any analysis compliance, tolerability or adverse 
events. 
Table 4. Subject’s “average level of pain” (0-10) score in Ibuki et al.9 
Baseline Mean ± (SD) 4.70 ± (1.63) 
12 weeks Mean ± (SD) 3.09 ± (1.85) 
Mean change from baseline (Calculated) -1.61 
P-value <0.01 
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Chapman et al. conducted a double blind, two arm parallel group randomized controlled 
trial to determine the effects of functional foot orthoses vs. sham control orthoses in adults with 
midfoot OA.10 Participants were recruited at an outpatient clinic and included if they were ≥ 18 
years of age, had diagnosed midfoot OA with radiographic evidence, or experienced midfoot 
pain for ≥ 3 months.10 Subjects were excluded if they had a history of inflammatory joint disease, 
neuropathy, stress fractures, lower limb surgery in the last year, or had existing use of OTC or 
prescription foot orthoses.10 A total of 37 participants were randomized into the functional foot 
orthoses group (n= 19) and sham orthoses control group (n=18).10 A total of 4 patients did not 
complete the study giving an attrition rate of 11%.10 One discontinued the functional foot 
orthoses due to pain related to the intervention.10 In the control group, one was lost to follow up 
and two discontinued intervention due to pain unrelated to the sham orthoses.10 Chapman et al. 
assessed subject’s average pain in the last month using an 11-point numeric rating scale scored 
from ‘no pain’ to ‘pain as bad as you can imagine’ at baseline and 12 weeks.10 Table 5 illustrates 
a mean change from baseline of patient’s “pain on average in last month” in both the functional 
foot orthoses group (-1.6 ± 2.0) and the sham orthoses group (-1.2 ± 1.1).10 Researchers 
calculated a mean difference of functional foot orthoses to sham orthoses is -0.4 (95% CI -1.6-
0.8) indicating a wide estimate of treatment effect making it difficult to determine the efficacy of 
both interventions. Chapman et al. also did not mention any analysis compliance, tolerability or 
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Table 5. Subject’s “pain on average in last month” (0-11) score in Chapman et al.10 
 
Functional Foot Orthoses (FFO) Group 
n = 19 
Sham Orthoses Group 
n = 18 
Baseline Mean ± (SD) 6.0 ± (1.6) 6.0 ± (1.9) 
12 weeks Mean ± (SD) 4.3 ± (1.9) 4.5 ± (1.9) 
Mean change from baseline ± (SD) -1.6 ± (2.0) -1.2 ± (1.1) 
Mean difference of FFO-sham (95% CI) -0.4 ± (-1.6 to 0.8) 
 
DISCUSSION 
Foot orthoses are commonly available in the United States, but the cost depends on 
several factors such as if the orthoses are over the counter (OTC), non-prescription orthoses 
made custom by do-it-yourself foot molds, or if a doctor prescribes them. Even when prescribed, 
depending on the patient’s health insurance, foot orthoses are sometimes excluded from 
coverage. According to CostHelper Health Incorporated, an online price quoting company, OTC 
foot orthoses cost about $10-$80, about $100-$200 for non-prescription orthotics, and about 
$200-$800 for prescription custom orthotics for uninsured patients and patients not covered by 
health insurance.11 
In terms of limitations of this review, when searching for randomized controlled trials 
studying efficacy of foot orthoses for foot osteoarthritis, results were scarce. The study 
conducted by Menz et al. was the first RCT to evaluate the effectiveness of mechanical 
interventions in reducing foot pain in people with first MTP joint OA.8 
In the study conducted by Menz et al., both interventions improved FHSQ pain scores. 
Researchers thought it possible that the rocker-sole shoes have a potential for greater 
effectiveness if barriers to adherence could be overcome.8 Since the orthoses group had higher 
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adherence and lower rates of adverse events, researchers thought it may be the preferred 
intervention.8 One major limitation of the study was that subjects were not blinded to the 
intervention. Since subjects were recruited via radio, newspaper, and social media 
advertisements and volunteered for the study, selection bias was introduced. As a result, 
generalizability of the study is questionable.  
In the case series conducted by Ibuki et al., researchers discussed that subjects who 
received carbon fiber footplates in addition to functional orthoses did not seem to experience 
greater relief than those who only received the functional orthoses, but a randomized controlled 
trial would be needed to determine if the carbon fiber footplate has any additional benefits.9 A 
major limitation of the Ibuki et al. case series was the lack of a control group. Researchers also 
commented on the reliability and validity of the questionnaires utilized.9 
In the randomized controlled trial conducted by Chapmen et al., researchers recognized 
that future studies with more objective and sensitives measures should be utilized to detect 
impairment and pain related function instead of subjective pain questionnaires.10 Researchers 
also noted that they would recommend a trial including a third, active monitoring arm with no 
planned treatment in order to better understand placebo effect.10 
CONCLUSIONS 
 The two randomized controlled trials and one case series in this review showed some data 
to suggest foot orthoses are effective at reducing pain in adults with foot osteoarthritis. However, 
future randomized controlled trials are needed to determine if foot orthoses are superior to other 
treatment options for foot OA. Though sample size and duration of treatment was sufficient for 
the three studies in this review, randomized controlled trials with larger sample sizes, longer 
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